Anzeige
Mehr »
Montag, 21.09.2026 - Börsentäglich über 12.000 News
114 Proben. 114 mit Gallium.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Renaissance Capital

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
07.08.SPAC Danneskjold and Galt Acquisition files for a $150 million IPO, targeting fintech and AI
07.08.Hong Kong-based fit-out provider Zensitive Holding files for a $25 million US IPO
07.08.SPAC Southport Acquisition II files for a $200 million IPO, targeting AI
07.08.SPAC OceanLight Acquisition prices $100 million IPO, led by SPAC veteran Ping Zhang
07.08.SPAC Pinnacle Acquisition prices $200 million IPO, targeting the financial sector
07.08.Latin American ticket platform Ticketplus prices US IPO at $8, the low end of the range
07.08.HydroThermal Reactor power plant developer KiNRG files for a $17 million IPO
07.08.SPAC Lucens Capital Acquisition I files for a $100 million IPO, targeting Argentina
07.08.BlossomHill Therapeutics prices upsized IPO at $16, the midpoint of the range
07.08.Latigo Biotherapeutics prices upsized IPO at $18, the high end of the range
07.08.SPAC Rainier Acquisition files for a $75 million IPO, targeting life sciences
06.08.Hong Kong digital marketing provider Poche Technology ups range to $5 to $7 ahead of $38 million US IPO
06.08.California-based River City Bank prices downsized IPO at $45, below the range
06.08.Cardiovascular diseases biotech Braveheart Bio prices upsized IPO at $18, above the range
06.08.Messaging infrastructure provider Spectral Capital sets terms for $15 million Nasdaq uplisting
05.08.SPAC Gravity Acquisition files for a $250 million IPO, targeting North America, Europe, and Asia
05.08.SPAC TCGX Acquisition prices $75 million IPO, targeting healthcare in Asia
05.08.Immune-focused biotech Attovia Therapeutics prices previously upsized IPO at $17, as expected
04.08.Luminous Acquisition, a SPAC led by an ARC Group executive, files for a $105 million IPO
04.08.Renaissance Capital's July IPO Market Update
04.08.Immune-focused biotech Attovia Therapeutics ups deal size by 45%, sets proposed price at $17 ahead of $289 million IPO
04.08.SPAC BOA Acquisition II prices $125 million IPO, targeting real estate and infrastructure
04.08.SPAC ARC Group Securities Acquisition I prices $105 million IPO, led by ARC Group executives
03.08.SPAC 1776 Acquisition files for a $150 million IPO, targeting tech-enabled businesses
03.08.Hong Kong-based nutrition products Fitness Fanatics more than triples shares offered ahead of $35 million US IPO